Esaote Launches Crystaline Ultrasound Technology at ECR 2014

 

March 5, 2014

March 5, 2014 — Esaote has launched CrystaLine, a significant evolution of its ultrasound technology that delivers new levels of accuracy, quality, versatility and value. Esaote will showcase the new technology at the 2014 annual meeting of the European Congress of Radiology in Vienna, March 6-10.

CrystaLine’s technical capabilities enable high-quality images to be captured at greater depth in the body. This significant improvement overcomes the challenges associated with larger and more technically difficult to scan patients.

CrystaLine incorporates specific hardware and software features that build on the advanced eHD ultrasound technology Esaote introduced last year. The reality of higher quality, clearer imaging at increased depth, now enables clinicians to confidently use ultrasound in borderline examinations and interventional ultrasound procedures. 

Carlos Faustmann, Esaote’s chief global marketing and domestic sales officer, said, “Ultrasound is highly valued for its safe, noninvasive nature, and continues to evolve and prove its value. One of the challenges has been capturing high-quality images in those technically difficult patients. CrystaLine changes that.”

Technical improvements provided by CrystaLine include combined pulse imaging technology, which effectively increases depth-of-field, improving the imaging of structures deeper in the body. Combined with the new XView+ speckle-noise reduction system, fully adjustable by the operator, it helps to produce an optimal personalized image.

Esaote systems with CrystaLine are also able to synchronize in real-time with therapeutic applications such as Echolaser to guide laser ablation and other procedures. “CrystaLine enables clinicians to synchronize with interventional systems such as medical lasers,” said Faustmann. “This feature plus the introduction of the 0 degrees biopsy-interventional dedicated probe, is an example of the huge potential for Esaote and ultrasound in direct therapeutic applications.”

CrystaLine is available across Esaote’s MyLabTwice, Seven and Alpha ultrasound systems.

For more information: www.esaote.com

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.